APA (7th ed.) Citation

Sayan, M., Vergalasova, I., Jhawar, S., Toppmeyer, D., Haffty, B., & Ohri, N. (2019). Utilization of Hypofractionated Whole-Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy. International Journal of Radiation Oncology, Biology, Physics, 105, E31. https://doi.org/10.1016/j.ijrobp.2019.06.688

Chicago Style (17th ed.) Citation

Sayan, M., I. Vergalasova, S.R Jhawar, D. Toppmeyer, B.G Haffty, and N. Ohri. "Utilization of Hypofractionated Whole-Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy." International Journal of Radiation Oncology, Biology, Physics 105 (2019): E31. https://doi.org/10.1016/j.ijrobp.2019.06.688.

MLA (9th ed.) Citation

Sayan, M., et al. "Utilization of Hypofractionated Whole-Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy." International Journal of Radiation Oncology, Biology, Physics, vol. 105, 2019, p. E31, https://doi.org/10.1016/j.ijrobp.2019.06.688.